Clintec is delighted to confirm that on 21st April 2017, it was awarded for the second time the Queen’s Award for Enterprise in the category of International Trade.
The Queen’s Award is regarded as the most prestigious business awards in the United Kingdom, identifying companies of significant excellence. The Award specifically highlights the consistent growth of Clintec in international markets over a number of years.
This accolade has been awarded as Clintec celebrates 20 years in business, during which time, operations have grown into over 50 international markets. This extensive geographical platform for clinical research, provides a valuable solution to the pharmaceutical and biotechnology industry, with the objective of bringing to market new therapies for patients in the most efficient and highest-quality manner.
The Leadership of the company acknowledge the contributions by its valued employees across the globe, in their unwavering endeavour to positively affect patient’s lives through clinical research execution and related support services.
Find out more about our recent award wins here.